175 related articles for article (PubMed ID: 31004097)
1. Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts.
Liu Y; Chanana P; Davila JI; Hou X; Zanfagnin V; McGehee CD; Goode EL; Polley EC; Haluska P; Weroha SJ; Wang C
Sci Rep; 2019 Apr; 9(1):6314. PubMed ID: 31004097
[TBL] [Abstract][Full Text] [Related]
2. Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts.
Cybulska M; Olesinski T; Goryca K; Paczkowska K; Statkiewicz M; Kopczynski M; Grochowska A; Unrug-Bielawska K; Tyl-Bielicka A; Gajewska M; Mroz A; Dabrowska M; Karczmarski J; Paziewska A; Zając L; Bednarczyk M; Mikula M; Ostrowski J
Biomed Res Int; 2018; 2018():2954208. PubMed ID: 30662905
[TBL] [Abstract][Full Text] [Related]
3. An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer.
Gitto SB; Kim H; Rafail S; Omran DK; Medvedev S; Kinose Y; Rodriguez-Garcia A; Flowers AJ; Xu H; Schwartz LE; Powell DJ; Simpkins F
Gynecol Oncol; 2020 Jan; 156(1):222-232. PubMed ID: 31818495
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of transcriptome in cancer patient-derived xenografts.
Li H; Zhu Y; Tang X; Li J; Li Y; Zhong Z; Ding G; Li Y
PLoS One; 2015; 10(5):e0124780. PubMed ID: 25951608
[TBL] [Abstract][Full Text] [Related]
5. Ovarian and cervical cancer patient derived xenografts: The past, present, and future.
Boone JD; Dobbin ZC; Straughn JM; Buchsbaum DJ
Gynecol Oncol; 2015 Aug; 138(2):486-91. PubMed ID: 26026736
[TBL] [Abstract][Full Text] [Related]
6. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004
[TBL] [Abstract][Full Text] [Related]
7. Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.
Harrington BS; He Y; Davies CM; Wallace SJ; Adams MN; Beaven EA; Roche DK; Kennedy C; Chetty NP; Crandon AJ; Flatley C; Oliveira NB; Shannon CM; deFazio A; Tinker AV; Gilks CB; Gabrielli B; Brennan DJ; Coward JI; Armes JE; Perrin LC; Hooper JD
Br J Cancer; 2016 Feb; 114(4):417-26. PubMed ID: 26882065
[TBL] [Abstract][Full Text] [Related]
8. Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts.
Pinessi D; Ostano P; Borsotti P; Bello E; Guffanti F; Bizzaro F; Frapolli R; Bani MR; Chiorino G; Taraboletti G; Resovi A
Connect Tissue Res; 2015; 56(5):355-63. PubMed ID: 25943461
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis.
Schneeberger VE; Allaj V; Gardner EE; Poirier JT; Rudin CM
PLoS One; 2016; 11(9):e0160587. PubMed ID: 27611664
[TBL] [Abstract][Full Text] [Related]
10. Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure.
Colombo PE; du Manoir S; Orsett B; Bras-Gonçalves R; Lambros MB; MacKay A; Nguyen TT; Boissière F; Pourquier D; Bibeau F; Reis-Filho JS; Theillet C
Oncotarget; 2015 Sep; 6(29):28327-40. PubMed ID: 26334103
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
12. [Application and development of patient-derived tumor xenograft model in translational medicine of tumor].
Wang Z; Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):596-600. PubMed ID: 28534338
[TBL] [Abstract][Full Text] [Related]
13. The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models.
Gómez-Miragaya J; Morán S; Calleja-Cervantes ME; Collado-Sole A; Paré L; Gómez A; Serra V; Dobrolecki LE; Lewis MT; Diaz-Lagares A; Eroles P; Prat A; Esteller M; González-Suárez E
Mol Cancer Res; 2019 Oct; 17(10):2063-2076. PubMed ID: 31320385
[TBL] [Abstract][Full Text] [Related]
14. The future of patient-derived tumor xenografts in cancer treatment.
Sia D; Moeini A; Labgaa I; Villanueva A
Pharmacogenomics; 2015; 16(14):1671-83. PubMed ID: 26402657
[TBL] [Abstract][Full Text] [Related]
15. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of renal cancer stem cells from patient-derived xenografts.
Hasmim M; Bruno S; Azzi S; Gallerne C; Michel JG; Chiabotto G; Lecoz V; Romei C; Spaggiari GM; Pezzolo A; Pistoia V; Angevin E; Gad S; Ferlicot S; Messai Y; Kieda C; Clay D; Sabatini F; Escudier B; Camussi G; Eid P; Azzarone B; Chouaib S
Oncotarget; 2016 Mar; 7(13):15507-24. PubMed ID: 26551931
[TBL] [Abstract][Full Text] [Related]
17. Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts.
Butler KA; Hou X; Becker MA; Zanfagnin V; Enderica-Gonzalez S; Visscher D; Kalli KR; Tienchaianada P; Haluska P; Weroha SJ
Neoplasia; 2017 Aug; 19(8):628-636. PubMed ID: 28658648
[TBL] [Abstract][Full Text] [Related]
18. A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.
Coussy F; de Koning L; Lavigne M; Bernard V; Ouine B; Boulai A; El Botty R; Dahmani A; Montaudon E; Assayag F; Morisset L; Huguet L; Sourd L; Painsec P; Callens C; Chateau-Joubert S; Servely JL; Larcher T; Reyes C; Girard E; Pierron G; Laurent C; Vacher S; Baulande S; Melaabi S; Vincent-Salomon A; Gentien D; Dieras V; Bieche I; Marangoni E
Int J Cancer; 2019 Oct; 145(7):1902-1912. PubMed ID: 30859564
[TBL] [Abstract][Full Text] [Related]
19. Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.
Heo EJ; Cho YJ; Cho WC; Hong JE; Jeon HK; Oh DY; Choi YL; Song SY; Choi JJ; Bae DS; Lee YY; Choi CH; Kim TJ; Park WY; Kim BG; Lee JW
Cancer Res Treat; 2017 Oct; 49(4):915-926. PubMed ID: 28052650
[TBL] [Abstract][Full Text] [Related]
20. Establishment of patient-derived xenograft model in ovarian cancer and its influence factors analysis.
Wu J; Zheng Y; Tian Q; Yao M; Yi X
J Obstet Gynaecol Res; 2019 Oct; 45(10):2062-2073. PubMed ID: 31385376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
